Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs Cyclopol for painless bronchoscopy sedation
ChiCTR2200067193Phase 4Not yet recruiting
- Sponsor
- Ordos Central Hospital
- Start
- Jan 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in anxiety disorder comparing Remimazolam arm with Cyclopol arm (2 arms). Primary endpoint: Operation completion success rate. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
remimazolamciprofol
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2200067193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067193.